Epigenetics Market growth is majorly driven by the high prevalence of cancer, increasing R & D funding and increasing intensity of genomic research activities. Other growth factors include increasing application for non-oncology diseases and growing partnership between academic, biotechnology and pharmaceutical companies.
The global epigenetics market is projected to reach USD 1.60 billion by 2022 from USD 0.85 billion in 2016, at a CAGR of 13.3% from 2017 to 2022.
Download FREE Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=896
The geographic segments included in this report are North America, Europe, Asia, and the Rest of the World (RoW). North America is further segmented into the U.S. and Canada. North America is expected to account for the largest share in the global epigenetics market in 2015. Asia is expected to register the fastest growth.
Epigenetics refers to the covalent modification of DNA, RNA, or protein that result in changes to the function and/or regulation of these molecules, without altering their primary sequences. Epigenetics has its applications in large number of fields including oncology, drug discovery, disease diagnosis, developmental biology and plant sciences. It is one of the most widely used techniques for cancer biomarkers discovery and development. According to GLOBOCON, 2012 prevalence of cancer is growing. For instance, there were 14.1 million new cancer cases, 8.2 million cancer deaths, and 32.6 million people living with cancer (within five years of diagnosis) in 2012 globally. A high prevalence of cancer will majorly drive the epigenetics market. Furthermore, factors such as an increasing research activities and R&D funding by private and government organizations will also aid to the growth of this market.
Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=896
Drug discovery segment is expected to grow at a higher rate during the forecast period. The emerging markets like Brazil, Russia, India and China provide potential growth opportunities for the growth of the global epigenetics market.
